GeNeuro Reports 2020 Full-Year Results and Provides Corporate Update - Seite 3

KEY FINANCIALS 2020

The Board of Directors of GeNeuro reviewed and approved the financial statements for the year ended December 31, 2020. The Statutory Auditors have conducted a review of the annual consolidated financial statements.

GeNeuro Consolidated Income Statement

(in thousands of EUR)

 

 

31/12/2020
12 months
Audited

31/12/2019
12 months
Audited

Income

 

 

-

-

Research and development expenses

 

 

 

 

Research and development expenses

 

 

(4,713.1)

(6,174.7)

Subsidies

 

 

556.0

912.4

General and administrative expenses

 

 

(3,302.0)

(3,744.1)

Other Income

 

 

-

16.2

Operating loss

 

 

(7,459.1)

(8,990.2)

 

 

 

 

 

Net loss for the period

 

 

(8,962.3)

(9,460.8)